Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Biden Administration Expected To Authorize Intradermal Injection Approach To Expand Monkeypox Vaccine Supply

    The New York Times (8/8, LaFraniere, Weiland) reports, “The Biden administration has decided to stretch out its limited supply of monkeypox vaccine by allowing a different method of injection that uses one-fifth as much per shot, according to people famil...
    Full Article
  • Pfizer, Valneva To Launch Clinical Trial Of Experimental Lyme Disease Vaccine

    USA Today (8/8, Weintraub) reports Pfizer and French partner Valneva “are launching a large clinical trial of an experimental vaccine that would be the first to prevent Lyme disease, the companies announced Monday.” VLA15, “if proven safe and effective......
    Full Article
  • BioNTech Expects To Begin Deliveries Of Omicron-Adapted Vaccines As Soon As October

    Reuters (8/8, Murray) reports, “BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its vaccine-revenue forecas...
    Full Article
  • Patients With COVID-19 Have Higher Risk For Hospital-Onset Antibiotic-Resistant Infections Compared With Patients With Influenza-Like Illness Before Pandemic, Study Finds

    Healio (8/8, Stulpin) reports, “Patients with COVID-19 had a higher risk for hospital-onset antibiotic-resistant infections compared with patients with influenza-like illness before the pandemic, according to a study.” The findings of the “retrospective s...
    Full Article
  • Climate Hazards Have Worsened More Than Half Of Human Infectious Diseases, Study Says

    The AP (8/8, Borenstein) reports, “Climate hazards such as flooding, heat waves and drought have worsened more than half of the hundreds of known infectious diseases in people, including malaria, hantavirus, cholera and anthrax, a study says.” Investigato...
    Full Article
  • Group Of 23 States Tells Federal Court CDC Lacks Authority To Set Transit Mask Rules

    Reuters (8/8, Shephardson) reports, “A group of 23 state attorneys general led by Florida told a federal court on Monday that the U.S. Centers for Disease Control and Prevention (CDC) lacks the legal authority to impose a nationwide transportation mask ma...
    Full Article
  • US Administers More Than 7,300 Doses Of Novavax COVID-19 Vaccine

    Reuters (8/5, Leo) reported the US “has administered more than 7,300 doses” of the Novavax COVID-19 vaccine, “which health officials hope will convince more people to opt for vaccinations as it is based on a technology that has been in use for decades.” M...
    Full Article
  • Finger Prick Nucleic Acid Testing USB-Interfaced Device May Increase Accessibility To HIV Self-Testing, Study Suggests

    Infectious Disease Advisor (8/5, Nguyen) reported that “a finger prick nucleic acid testing (NAT) USB-interfaced device can increase accessibility to HIV self-testing, according to” a study. The findings were outlined in Biosensors and Bioelectronics.
    Full Article
  • Increase In Incidence Of Endophthalmitis Following Vitrectomy May Be Tied To Increased Mask Wearing During COVID-19 Pandemic, Study Suggests

    Infectious Disease Advisor (8/5, Wild) reported, “An increase in the incidence of endophthalmitis following vitrectomy between 2019 and the period between July 2020 and June 2021 suggests an association with increased mask wearing during this period, acco...
    Full Article
  • Experts Express Caution Over Proposed Monkeypox Vaccination Strategy To Ease Shortage

    The New York Times (8/6, LaFraniere, Weiland) reported a proposed approach to address the shortage of monkeypox vaccine in the US – “injecting one-fifth of the current dose into the skin instead of a full dose into underlying fat – is not actually all tha...
    Full Article
  • Patients In US Struggle To Obtain Monkeypox Drug Due To Limited Access

    The New York Times (8/6, Mandavilli) reported, “The only drug available to treat monkeypox is so difficult to access that just a fraction of the nearly 7,000 patients in the United States have been given it.” Health officials “designated tecovirimat, also...
    Full Article
  • Siga Technologies To Begin First Human Trial Of Its Monkeypox Drug In September

    Bloomberg Law (8/5, Muller, Subscription Publication) reported, “Siga Technologies Inc.’s Tpoxx [tecovirimat], a monkeypox treatment stockpiled by the US, will undergo its first rigorous human test in a trial slated to open as soon as September.” The arti...
    Full Article
  • Dr. Jha Touts Monkeypox Public Health Emergency Declaration, Says No “Reason For Widespread Alarm”

    CBS News (8/5) reported White House Coronavirus Response Coordinator Dr. Ashish Jha, “who is assisting on the monkeypox virus response, told ‘CBS Mornings’ that declaring a public health emergency will help speed up vaccinations, treatment and the acquisi...
    Full Article
  • Dr. Fauci Urges People In US To Monitor Monkeypox Outbreak But Not To Panic

    The Washington Post (8/6, Bever) reported that amid the monkeypox outbreak in the US, NIAID Director Dr. Anthony Fauci “said people should be paying attention but not panicking.” Dr. Fauci “told WTOP News that people do not need to change the way they liv...
    Full Article
  • Biden Administration Declares Monkeypox Outbreak Public Health Emergency

    The Washington Post (8/4, Diamond) reports HHS Secretary Xavier Becerra “declared the monkeypox outbreak a public health emergency on Thursday in an effort to galvanize awareness and unlock additional flexibility and funding to fight the virus’s spread.”...
    Full Article
  • Biden Administration Weighing Dose-Sparing Approach To Increase Monkeypox Vaccine Supply

    The Hill (8/4, Choi) reports, “The Biden administration is considering splitting doses of the smallpox vaccine, which are being used to prevent monkeypox amid the current outbreak, into five smaller doses...said” FDA Commissioner Dr. Robert Califf on Thur...
    Full Article
  • Children Granted Access To Monkeypox Vaccine On Case-By-Case Basis, FDA Says

    ABC News (8/4, Kindelan, Salzman) reports, “With over 6,000 cases of monkeypox confirmed in the United States, including five children, the demand for the monkeypox vaccine is high.” Although “the current vaccine, JYNNEOS, is approved only for adults ages...
    Full Article
  • Experts Question Timing, Effectiveness Of Updated COVID-19 Vaccine Boosters

    CNN (8/4, Christensen) reports, “This fall, Americans could get boosted with a mRNA COVID-19 vaccine unlike any that’s come before,” as “both Pfizer and Moderna are working on bivalent boosters: vaccines made up of both the old formula and a new one that...
    Full Article
  • Researchers Outline List Of Core Symptoms That May Offer Better Working Definition Of Long COVID

    MedPage Today (8/4, Short) reports that in an article published in The Lancet, “researchers proposed a list of core symptoms that could offer a better working definition of long COVID, based on an observational cohort study from the Netherlands.” Among ov...
    Full Article
  • Global Rate Of Macrolide-Resistant Mycoplasma Pneumoniae Infections Has Increased, Systematic Review And Meta-Analysis Find

    Infectious Disease Advisor (8/4, Nye) reports results of a 150-study systematic review and meta-analysis “found that the global rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) infections has increased, highlighting the need for effective strategi...
    Full Article
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id